Iridex (IRIX) Non-Current Deferred Tax Liability (2022)

Iridex's (IRIX) quarterly Non-Current Deferred Tax Liability came in at $104000.0 in Q4 2022.

Iridex (IRIX) Non-Current Deferred Tax Liability (2022) Analysis & Trends

Iridex's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $104000.0 for Q4 2022.

On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $104000.0 in Q4 2022; TTM through Dec 2022 was $104000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $104000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability held at $104000.0 in Q4 2022 per IRIX's latest filing.
Across five years, Non-Current Deferred Tax Liability topped out at $104000.0 in Q4 2022 and bottomed at $104000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Iridex	15.93 Mn	11.33 Mn	4.74 Mn

Download Data

Date	Value
Dec 31, 2022	104,000.00
Dec 31, 2022	104,000.00